These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18988808)

  • 21. Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization.
    Berkowitz P; Hu P; Liu Z; Diaz LA; Enghild JJ; Chua MP; Rubenstein DS
    J Biol Chem; 2005 Jun; 280(25):23778-84. PubMed ID: 15840580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity.
    Mavropoulos A; Orfanidou T; Liaskos C; Smyk DS; Spyrou V; Sakkas LI; Rigopoulou EI; Bogdanos DP
    Autoimmune Dis; 2013; 2013():728529. PubMed ID: 23936634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pemphigus, a pathomechanism of acantholysis.
    Furue M; Kadono T
    Australas J Dermatol; 2017 Aug; 58(3):171-173. PubMed ID: 28211055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology.
    Marchenko S; Chernyavsky AI; Arredondo J; Gindi V; Grando SA
    J Biol Chem; 2010 Feb; 285(6):3695-3704. PubMed ID: 20007702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris.
    Mavropoulos A; Orfanidou T; Liaskos C; Smyk DS; Billinis C; Blank M; Rigopoulou EI; Bogdanos DP
    Autoimmun Rev; 2013 Mar; 12(5):580-90. PubMed ID: 23207287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction.
    Heupel WM; Zillikens D; Drenckhahn D; Waschke J
    J Immunol; 2008 Aug; 181(3):1825-34. PubMed ID: 18641320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus.
    Spindler V; Eming R; Schmidt E; Amagai M; Grando S; Jonkman MF; Kowalczyk AP; Müller EJ; Payne AS; Pincelli C; Sinha AA; Sprecher E; Zillikens D; Hertl M; Waschke J
    J Invest Dermatol; 2018 Jan; 138(1):32-37. PubMed ID: 29037765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The plant lectin wheat germ agglutinin inhibits the binding of pemphigus foliaceus autoantibodies to desmoglein 1 in a majority of patients and prevents pathomechanisms of pemphigus foliaceus in vitro and in vivo.
    Ortiz-Urda S; Elbe-Bürger A; Smolle J; Marquart Y; Chudnovsky Y; Ridky TW; Bernstein P; Wolff K; Rappersberger K
    J Immunol; 2003 Dec; 171(11):6244-50. PubMed ID: 14634141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation.
    Kawasaki H; Tsunoda K; Hata T; Ishii K; Yamada T; Amagai M
    J Invest Dermatol; 2006 Dec; 126(12):2621-30. PubMed ID: 16841036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3.
    Spindler V; Drenckhahn D; Zillikens D; Waschke J
    Am J Pathol; 2007 Sep; 171(3):906-16. PubMed ID: 17640963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodies.
    Spindler V; Vielmuth F; Schmidt E; Rubenstein DS; Waschke J
    J Immunol; 2010 Dec; 185(11):6831-8. PubMed ID: 21037102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor.
    Heupel WM; Engerer P; Schmidt E; Waschke J
    Am J Pathol; 2009 Feb; 174(2):475-85. PubMed ID: 19147829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
    Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
    Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin.
    Li N; Zhao M; Wang J; Liu Z; Diaz LA
    J Immunol; 2009 Jan; 182(1):711-7. PubMed ID: 19109205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of acantholysis in pemphigus foliaceus.
    España A; Diaz LA; Mascaró JM; Giudice GJ; Fairley JA; Till GO; Liu Z
    Clin Immunol Immunopathol; 1997 Oct; 85(1):83-9. PubMed ID: 9325073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.
    Luyet C; Schulze K; Sayar BS; Howald D; Müller EJ; Galichet A
    PLoS One; 2015; 10(3):e0119809. PubMed ID: 25748204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of blister induction by autoantibodies.
    Sitaru C; Zillikens D
    Exp Dermatol; 2005 Dec; 14(12):861-75. PubMed ID: 16274453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice.
    Kim AL; Labasi JM; Zhu Y; Tang X; McClure K; Gabel CA; Athar M; Bickers DR
    J Invest Dermatol; 2005 Jun; 124(6):1318-25. PubMed ID: 15955110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pemphigus as a paradigm of autoimmunity and cell adhesion.
    Amagai M
    Keio J Med; 2002 Sep; 51(3):133-9. PubMed ID: 12371644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.